Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YanShu Curative Effect on Bone Metastases of Lung Cancer
ChiCTR-OIC-16008459Phase 4Recruiting
- Sponsor
- Anhui Chest Hospital
- Start
- May 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of compound kushen injection in bronchial carcinoma and bone metastases (4 arms), sponsored by Anhui Chest Hospital. Primary endpoints: Bone related events, Bone metastasis and 1 more. Started May 2016; status: recruiting.
02
Drugs
compound kushen injection
03
Conditions
bronchial carcinomabone metastases
Beyond the preview
Go deeper on ChiCTR-OIC-16008459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-16008459.